This page uses JavaScript to progressively load the article content as a user scrolls.
Screen reader users, click the load entire article button to bypass dynamically loaded article content.
&RIS&(for EndNote, Reference Manager, ProCite)
&RefWorks Direct Export
& Citation Only
& Citation and Abstract
JavaScript is disabled on your browser.
Please enable JavaScript to use all the features on this page.
JavaScript is disabled on your browser.
Please enable JavaScript to use all the features on this page. This page uses JavaScript to progressively load the article content as a user scrolls. Click the View full text link to bypass dynamically loaded article content.
1987, Pages 885–890VOLUME II
CONCRETE STRENGTH & COMPARISON BETWEEN NON-DESTRUCTIVE TESTS Lecturer, Federal University Rio de Janeiro, Head, Road Research Centre, Roda Research Institute, Rio de Janeiro, BrazilThis paper analyses the effectiveness of the various tests in evaluating compressive strength, taking into account the correlation curve and its residual standard deviation.For carrying out the research tests of compressive strength, fracture by expanding a sleeve, ultrasonic pulse velocity, penetration impact and Schmidt hammer have been done.
No articles found.
This article has not been cited.
No articles found.References
Do you want to read the rest of this conference paper?
CitationsCitations0ReferencesReferences3ABSTRACT: CD4(+) regulatory T cells (Tregs) play an important role in maintaining immune tolerance by suppressing pathologic immune responses. The generation of large numbers of antigen-specific Tregs ex vivo is critical for the development of clinical immunotherapy based on the adoptive transfer of Tregs. Both CD40-activated B cells (CD40-B) and immature dendritic cells (imDCs) have been used as professional antigen-presenting cells (APCs) to generate antigen-specific Tregs. However, the efficiencies of CD40-B and imDCs to generate CD4(+) Tregs have not been compared directly and the mechanism driving the generation of these Tregs remains largely unknown. In this study, we found that CD40-B exhibited mature phenotypes and were more able to induce and expand CD4(high)CD25(+) Tregs than imDCs. Moreover, Tregs induced by CD40-B had greater suppressive capacity than those induced by imDCs. The generation of CD4(high)CD25(+) Tregs by CD40-B and imDCs is cell-cell contact dependent and partially relies on the expression of human leukocyte antigen (HLA)-DR and CD80/86. Differences in CD4(high)CD25(+) Treg generation efficiency were largely explained by the production of endogenous IL-2 by CD40-B. Our results suggest that CD40-B is better able to generate large numbers of antigen-specific Tregs than imDCs. Additionally, using CD40-B to generate Tregs may accelerate the clinical use of Treg-based immunotherapy in the treatment of allograft rejection, graft versus host disease (GVHD) and autoimmune diseases. Full-text · Article · Jan 2010 ABSTRACT: Analysis of cytokine and differentiation antigen expression in human natural killer (NK) cells revealed that interleukin 13 (IL-13) and interferon gamma (IFN-gamma) are produced at sequential stages during irreversible IL-12-induced differentiation. In human NK cell clones, polyclonal CD3-CD161+CD56- cells and peripheral lymphocytes, IL-4 induced the proliferation of both IL-13+ NK and T cells, whereas IL-12 allowed a proliferation-independent accumulation of IFN-gamma+ cells. These data disproved the NK1-NK2 hypothesis and challenge the current T helper 1 (TH1)-TH2 paradigm. We propose that the cytokine environment regulates a type 2--&0--&1 developmental progression, with IL-12 needed for terminal differentiation and IL-4 delaying this process, rather than a type 1 versus type 2 decision of a type 0 cell.Article · Oct 2001 ABSTRACT: Adoptive T-cell therapy using CD3/CD28 co-stimulation likely requires in vivo generation of antigen specificity. Because CD28 promotes TH1/TC1 (T1) or TH2/TC2 (T2) differentiation, costimulation may generate donor T1 or T2 cells capable of differentially mediating allogeneic graft-versus-tumor (GVT) effects and graft-versus-host disease (GVHD). Costimulation under T1 or T2 conditions indeed generated murine TH1/TC1 cells secreting interleukin-2/interferon-gamma (IL-2/IFN-gamma) or TH2/TC2 cells secreting IL-4/IL-5/IL-10. In vivo, allogeneic T1 cells expanded, maintained T1 secretion, and acquired allospecificity involving IFN-gamma and IL-5. In contrast, allogeneic T2 cells expanded less and maintained T2 secretion but did not develop significant allospecificity.Allogeneic, but not syngeneic, T1 cells mediated a GVT effect against host-type breast cancer cells, as median survival time (MST) increased from 25.6 +/- 2.6 (tumor controls) to 69.2 +/- 5.9 days (P & 1.2 x 10(-9)). This T1-associated GVT effect operated independently of fasL because T1 cells from gld mice mediated tumor-free survival. In contrast, allogeneic T2 cells mediated a modest, noncurative GVT effect (MST, 29 +/- 1.3 P &.0019). T1 recipients had moderate GVHD (histologic score, 4 of 12) that contributed to lethality after bone ma in contrast, T2 recipients had minimal GVHD (histologic score, 1 of 12). CD3/CD28 co-stimulation, therefore, generates T1 or T2 populations with differential in vivo capacity for expansion to alloantigen, resulting in differential GVT effects and GVHD. Full-text · Article · Dec 2003 +1 more author...Article · Oct 2017 R. MaM. LevyB. Gui+1 more author...S.E. LuArticle · Oct 2017 S. Julian SerranoJ. Pérez-MayoralM. Soto-Salgado+1 more author...M.E. Pérez-HernándezArticle · Oct 2017 Xiaoxu WangChristopher HewsionRobert Litchfield+1 more author...Dianne Margaret BryantData provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.This publication is from a journal that may support self archiving.Options for accessing this content: If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
If your institution does not currently subscribe to this content, .Login via other institutional login options .You can purchase online access to this Article for a 24-hour period (price varies by title)
If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.New Users: Please register, then proceed to purchase the article.
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
Access your saved publications, articles and searchesManage your email alerts, orders and subscriptionsChange your contact information, including your password
Please register to:
Save publications, articles and searchesGet email alertsGet all the benefits mentioned below!}